RxDoctor Payments Data

Andrew Bukowinski

Pediatric Hematology-Oncology · Cincinnati, OHNPI 1184853814

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $370 of the $370 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Pfizer. That places this record below the midpoint for pediatric hematology-oncology clinicians in OH, where the typical reported total is $705.

$370in general payments, 2019–2025

Across 1 payment — averaging $370.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$370
$3,480,274in research payments, 2019–2025

Across 31 payments — averaging $112,267 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$3.4M
  • Pfizer$47K
  • Bayer$1K
  • Eli Lilly$476
  • Incyte Corporation$191

What the payments were for

  • Consulting fees$370100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer1$370

How this compares

$370 in reported general payments places this provider in the 45th percentile of 143 pediatric hematology-oncology providers in Ohio.

See all pediatric hematology-oncology providers in Ohio

Other pediatric hematology-oncology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →